hUC-MSCs

human umbilical cord-derived mesenchymal stem cells · Shenzhen Wingor Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for hUC-MSCs, covering 2019-01-25 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS [Phase 2]

See pricing